| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.45 | 0.005 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |